When the same individuals with T2D repeated the arginine infusion test after eight weeks of diet, insulin, or sulfonylurea therapy, their hormonal responses were improved from their own pre-treatment levels (i.e., lower glucagon release and higher insulin release, resulting in lower blood glucose), but remained worse than the non diabetic controls. The gene discussed is INS; the disease is type 2 diabetes mellitus.